DUBLIN–(BUSINESS WIRE)–The “Global Psychedelic Drugs Market Size & Share to 2027” report has been added to ResearchAndMarkets.com’s offering.
Increase in prevalence of depression across the globe is the key driving factor which is expected to boost the global psychedelic drugs market growth. Furthermore, change in lifestyle and requirement for enhanced and better life quality will positively contribute the market growth.
Also, increase in research and development activities is expected to propel the market growth during this analysis period. Moreover, increase in dependency on psychedelic drugs for treatment of depression is expected to propel the global psychedelic drugs market growth during this forecast period.
However, stringent rules and regulations imposed by government to commercialize psychedelic drugs is the major challenging factor which is expected to hinder the global psychedelic drugs market growth. Also, poor efficiency and safety profile of existing intervention will affect the market growth over the forecast period.
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Psychedelic Drugs Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Market Key Players
- AstraZeneca
- COMPASS
- Klarisana
- F. Hoffmann-La Roche Ltd
- Takeda Pharmaceutical Company Limited
- Dr. Reddy’s Laboratories Ltd
- Pfizer Inc
- Merck & Co. Inc
- Lundbeck A/S
Market Taxonomy
By Drug Type
- Lysergic Acid Diethylamide (LSD)
- 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
- Phencyclidine
- Gamma Hydroxybutyric Acid (GHB)
- Ketamine
- Ayahuasca
- Salvia
- Psilocybin
- Others
By Route of Administration
- Oral
- Injectable
- Inhalation
By Distribution Channel
- Direct Retailers
- Online Pharmacies
- Others
By End-User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Global Psychedelic Drugs Market Outlook
5 Global Psychedelic Drugs Market, By Drug Type
6 Global Psychedelic Drugs Market, By Route of Administration
7 Global Psychedelic Drugs Market, By Distribution Channel
8 Global Psychedelic Drugs Market, By End User
9 Global Psychedelic Drugs Market, By Region
For more information about this report visit https://www.researchandmarkets.com/r/2k3b4y
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900